Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (12)

2022

  1. Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain

    Cancer Epidemiology, Vol. 76

  2. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression

    Journal of Investigative Dermatology, Vol. 142, Núm. 5, pp. 1391-1400.e15

2018

  1. Mycosis fungoides progression could be regulated by microRNAs

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. A Case with Juvenile Xanthogranuloma and Progressive Nodular Histiocytosis Overlap

    Pediatric Dermatology, Vol. 34, Núm. 2, pp. e102-e103

2015

  1. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma

    Haematologica

  2. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas

    Haematologica

2014

  1. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  2. PLCG1 mutations in cutaneous T-cell lymphomas

    Blood, Vol. 123, Núm. 13, pp. 2034-2043

  3. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

    Modern Pathology, Vol. 26, Núm. 2, pp. 171-181

  2. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

  3. TCR-γ expression in primary cutaneous T-cell lymphomas

    American Journal of Surgical Pathology, Vol. 37, Núm. 3, pp. 375-384